Given the recent focus on the issue of transparency surrounding physician-industry relationship, a number of additional regulatory steps are rapidly beginning to evolve.
Individual State Policies
Several states, including Maine, West Virginia, Minnesota, and Vermont, as well as the District of Columbia, have created laws that provide for public access to payments made to physicians from pharmaceutical or device companies.
Association of American Medical Colleges (AAMC)
Citing the need for an effective and principled partnership between academic medical centers and various health industries in order to fully realize the benefits of biomedical research and ensure continued advances in the prevention, diagnosis, and treatment of disease, the AAMC published a position statement on industry funding for medical school programs.(16)